Danaher enters bioprocessing world with completion of Pall deal
Danaher has become a major player in upstream and downstream technologies through the completion of its $14bn acquisition of Pall Corporation.
Archives for September 1, 2015
Boehringer-Ingelheim licenses microbial expression tech for in-house and out
Boehringer Ingelheim has licensed a microbial expression technology from Vectron Biosolutions for use with its own molecules and for customers through its CMO business.